Freund's adjuvant, used by others to stimulate the reticuloendothelial system of small laboratory animals, produced granulomas resembling sarcoid in the lung of the dog. At the height of the disease, when granulomas occupied more than half of the alveolar tissues, transpulmonary arteriovenous (A-V) differences of lactate, pyruvate, and glucose were measured._When the diseased dogs breathed room air, the A-V differences of lactate and pyruvate were greater than normal; and when the dogs breathed an hypoxic mixture, the differences increased further. Hence the model affords the opportunity for studying the in vivo metabolism of diseased lungs. It may also prove useful for studying other aspects of granulomatous disease which cannot be easily approached in man.
INTRODUCTION
Compared to the information available on most aspects of proliferative pulmonary disorders, knowledge of the in vivo metabolism of the diseased lung is meager. Even in active tuberculosis, where the lung appears to have an enhanced energy consumption (1) , the metabolic behavior of the lung is uncertain because transpulmonary arteriovenous (A-V) differences of metabolites have not shown consistent patterns. One contributing factor has been the large ratio of blood flow to tissue mass in the lung, a circumstance tending to minimize the A-V difference of any metabolite. Another factor has been the inhomogeneous distribution of pulmonary lesions, a condition which may cause differences This work was presented as an abstract. Strauss Received for 'publication 5 May 1969 and in revised form 3 March 1970. across involved regions to be diluted to unmeasurably small values by blood perfusing normal lobules. This latter effect was demonstrated in an earlier study of lactate metabolism in the lungs of patients undergoing thoracotomy for tuberculosis (2) . Whereas the difference across each diseased lobe or lobule showed a definite production of lactate, the difference across both lungs was often near zero.
To circumvent the difficulties inherent in measuring A-V differences in man, we sought an experimental model in which the involvement of the lung would be so extensive that the diluting effect would be minimized. We therefore investigated the feasibility of utilizing in dogs a method employed by others to evoke a granulomatous response in smaller laboratory animals (3, 4 'Glucostat, Worthington Biochemical Corp., Freehbld, N. J. the carina, and the heart and mediastinal structures were cut away. After being filled with 10% formalin, the lungs were placed in a formalin bath for 72 hr before being processed for histologic and morphometric studies. Four samples of tissue, each measuring approximately 3.0 X 1.5 cm, were removed from the peripheral portion of the right lung, and four from the left. The eight pieces were imbedded in paraffin, then cut and stained with hematoxylin and eosin. From the eight specimens, four were chosen at random for analysis by the point-counting method of Chalkley (8) . This method, adapted to the lung by Weibel and Gomez (9) and applied by Dunnill (10) and by Strauss (11) , entailed examining sections of lung with a microscope equipped with a Zeiss integrating eyepiece holding a grid of 25 points. 11 fields were examined in each specimen, and the number of grid points touching the various structures were recorded. By this technique the lung was divided into normal and abnormal components. Since the grid contained 25 points, the analysis embraced 25 points X 11 fields X 4 specimens = 1100 points for each dog.
RESULTS
Gross and microscopic features of the diseased lung. The injection of adjuvant produced florid lesions in the lungs of the majority of dogs. While the time course of the development of lesions was variable, most dogs showed extensive pulmonary involvement by the begining of the 3rd wk. From this time to the end of the 4th wk the lesions in the lung remained at a rather constant level, and thereafter regressed.
At the height of the disease the surface of the lung had a dark raspberry color. Palpable nodules, with diameters up to 5 mm, were diffusely distributed over the pleura. When examined under low-power magnification, the lungs appeared to be filled with both discreet and conglomerate lesions. Under high-power most of the lesions had structures characteristic of granulomas, with epithelioid cells surrounded by lymphocytes, polymorphonuclear leukocytes, and plasma cells. There were occasional eosinophils. Although cavitation was not seen, some fields contained small holes which lipid stains showed to be filled with fat. The droplets presumably came from the paraffin oil of the injected adjuvant.
The results of point-counting are presented in Table  I . On the average, 56% of the lung was granulomatous and diseased hypoxic dogs (group IV) revealed that increments in the A-V differences of lactate and pyruvate were highly significant (P < 0.001). Further, diseased hypoxic dogs (group IV) had wider A-V differences than diseased dogs breathing 21% oxygen (group II). The increment for lactate would have occurred by chance less frequently than 1 time in 100 (P < 0.01) and for pyruvate less frequently than 1 time in 20 (P < 0.05). Since the increase in A-V lactate difference was greater than that for pyruvate, the L/P ratio increased (P < 0.05) in the diseased dogs during hypoxia.
Unlike the A-V difference of lactate and pyruvate, the A-V difference of glucose was unaffected by disease or hypoxia.
Important to all of these observations was the fact that the degree of hypoxia, as judged by the calculated alveolar oxygen tension, was comparable in the control (group III) and diseased (group IV) dogs. The range of alveolar oxygen tension for each group was 55-65 mm Hg.
DISCUSSION
In the past, complete Freund's adjuvant has been used to evoke a granulomatous response in small laboratory animals, including rabbits, mice, rats, and hamsters. One study, performed by Moore and Schoenberg in rabbits (5), traced the development of lesions in the lung. The granulomas appeared 3 days after the injection of adjuvant, increased in number to the 4th wk, and then slowly regressed. In the present study the pulmonary lesions in the dog followed a similar time course of development and regression.
When compared to lung diseases in man, the lesions in the dog resemble in morphology and distribution the noncaseating granulomatous pulmonary disorders, thereby providing a model of human disease. Moreover, the value of the model is enhanced by a number of advantageous features. First, the dog is not severely ill and can be studied by standard methods. Second, his blood volume is sufficiently large to permit withdrawal of several blood samples. Third, the disease does not produce adhesions, so the possibility that vessels connecting the chest wall and lungs will complicate the analysis of either blood flow or A-V difference is eliminated. Fourth, the time-course of the disease affords an opportunity to study the process in the lung at different stages. And finally, the dispersion of the lesions throughout the pulmonary tissue minimizes the diluting effect of blood flow through normal regions.
A large number of reports have presented data on transpulmonary differences of lactate in men and animals. While the majority of the human studies have failed to find a significant difference, the study by Bucherl and Schwab (14) showed, on the average, an increase in lactate concentration of blood perfusing the lung in a large group of patients, many of whom had proliferative lung disease. In respect to pyruvate, neither Bolt, Schild, Valentin, and Venrath (15) nor Harris et al. (16) found a significant A-V difference across the normal human lung. None of these studies, however, is exactly comparable to that which we performed. In the first place, the lungs of our dogs were diffusely involved by granulomas, and in the second place, the dogs were made hypoxic.
The interpretation of the A-V differences of lactate and pyruvate remains to be considered. Although production of these metabolites by granulomata seems the most likely explanation, other possibilities exist. One is the formation of these metabolites by red cells during the seconds required for their transit between sampling sites. It can be estimated from in vitro measurements of the rate of lactate production (17) that the red cells would have had to remain in transit for several minutes to produce the increments in lactate and pyruvate which we found in the hypoxic diseased dogs.
A second possibility is that the widened A-V differences of lactate and pyruvate resulted from a reduced blood flow during disease or during disease plus hypoxia. Cited alone, A-V differences give no information about the total amounts of substances being metabolized and for this reason, the ideal study matches each A-V difference with a measurement of blood flow. Although aware of this fact, we intentionally designed the present study to measure only A-V differences. The point seemed important because Lochner, Piiper, Schurmeyer, and Bostroem (18) demonstrated through a series of cross perfusion experiments that hemorrhage can substantially affect the A-V difference of lactate in the dog. Hence, to determine whether disease or disease plus hypoxia changed the pulmonary blood flow, we measured flow by the dye dilution method under identical conditions in a second series of normal and diseased dogs. 19 measurements in five control dogs breathing 21% oxygen gave a mean value of 137/ml per min per kg; while 15 measurements in four disease dogs breathing 14% oxygen gave a mean flow of 141/ml per min per kg (19) . Since both disease and hypoxia left blood flow virtually unchanged, it seems unlikely that the consistent increase in A-V differences of lactate and pyruvate reflected a change in perfusion of the diseased hypoxic lung.
A third alternative merits consideration. This concerns the question of reaching a steady state for lactate and pyruvate exchanges in the pulmonary circulation during an experimental period of 20 min. Our data do not answer the question, but measurements of the respiratory quotient, one of the indices of steadiness, showed that values were virtually the same in all four groups of dogs.
The influence of hypoxia on the metabolism of the diseased lung is difficult to evaluate. When the alveolar oxygen tension was reduced by breathing an hypoxic mixture, other variables, such as the blood carbon dioxide tension and pH, simultaneously changed. The possibility therefore arises that the changes in A-V differences seen are related to alkalosis in the diseased pulmonary tissues. Huckabee has shown that a threefold increase in ventilation produces a rise in arterial levels of lactate and pyruvate in anesthetized dogs (20) . The contribution of the pulmonary tissues to these changes is not known, hence a comparison to the present data is not readily available. On the other hand, ZborowskaSluis and Dosseter (21) measured arteriovenous differences of lactate across normal liver, muscle, brain, kidney, and gut in hyperventilated anesthetized dogs, but found no changes.
Regardless of the precise mechanism, the A-V differences in lactate and pyruvate probably reflect the metabolism of the diseased pulmonary tissues. Additional evidence that diseased lung may produce lactate comes from the earlier study performed during thoracotomy (2). Here differences measured directly across tuberculous regions invariably showed higher concentrations of lactate in blood draining the lobe.
The experiments have not settled the matter of substrate for the diseased lung since the AV differences of glucose did not show any measurable change. Assuming glucose were the substrate, one would expect its A-V differences to be half that measured for lactate, giving a mean value of 0.14/mm per liter of glucose for the diseased, hypoxic dogs (group IV). Based on the reproducibility of the glucose measurements in our hands, this difference would approach the error of the method. Hence the failure to see a glucose difference is not inconsistent with the role of glucose as substrate in the lung, a topic recently reviewed by Heinemann and Fishman (22) .
